Design and development of an aptamer targeting C-type lectin-like molecule-1 as a biomarker for acute myeloid leukemia: a SELEX approach
Acute myeloid leukemia (AML), a hematologic malignancy, is an important public health issue. It is a result of the abnormal proliferation of immature myeloid cells. Despite advancements in diagnostic procedures, the early identification of AML remains a significant clinical challenge, marking a dist...
Saved in:
| Main Authors: | Yiwen Chen, Qinhang Li, Shifeng Lou, Hanqing Zeng, Shu Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Bioengineering and Biotechnology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fbioe.2025.1601453/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advantages, applications, and future directions of in vivo aptamer SELEX: A review
by: Minchuan Lyu, et al.
Published: (2025-09-01) -
Progress in Aptamer Research and Future Applications
by: Song Liu, et al.
Published: (2025-07-01) -
Advancements in SELEX Technology for Aptamers and Emerging Applications in Therapeutics and Drug Delivery
by: Liangjie Feng, et al.
Published: (2025-06-01) -
A novel hybrid approach to overcome defects of CE-SELEX and cell-SELEX in developing aptamers against aspartate β-hydroxylase
by: Hadi Bakhtiari, et al.
Published: (2025-01-01) -
Targeting ocular tissues with intravenously administered aptamers selected by in vivo SELEX
by: Sonja Korhonen, et al.
Published: (2024-12-01)